The Interferon Gamma-1b Injection, cataloged under National Stock Number 6505-01-352-2216, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Horizon Therapeutics Usa, Inc. Dba Horizon Therapeutics Usa Inc. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-352-2216 |
| Primary Part Number | NDC42238-0111-12 |
| Item Name | Interferon Gamma-1b Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Horizon Therapeutics Usa, Inc. Dba Horizon Therapeutics Usa Inc |
| Status | ACTIVE |
| Therapeutic Equivalent | ACTIMMUNE BY GENENTECH INC |
| Administration | SUBCUTANEOUS |
| Primary Container Content Quantity | 0.500 MILLILITERS |
| Features Provided | STERILE |
| Primary Container Type | VIAL, SINGLE DOSE |
| Total Primary Container Quantity | 12 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC42238-0111-12 PRIMARY | Horizon Therapeutics Usa, Inc. Dba Horizon Therapeutics Usa Inc (USA) |
| Reference | Meaning |
|---|---|
| ACTIMMUNE | 5/1 Secondary reference Horizon Therapeutics Usa, Inc. Dba Horizon Therapeutics Usa Inc |
NSN 6505-01-352-2216 is a Interferon Gamma-1b Injection, manufactured by Horizon Therapeutics Usa, Inc. Dba Horizon Therapeutics Usa Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-352-2216 has 1 manufacturer part number on file: NDC42238-0111-12 (Horizon Therapeutics Usa, Inc. Dba Horizon Therapeutics Usa Inc).
Key specifications for NDC42238-0111-12: Therapeutic Equivalent: ACTIMMUNE BY GENENTECH INC; Administration: SUBCUTANEOUS; Primary Container Content Quantity: 0.500 MILLILITERS; Features Provided: STERILE. 6 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.